Skip to content Skip to menu

HCOs & Patients

This section is for Health Consumer Organisations and patients, and provides relevant and useful information on COVID-19.

We are in this together – everyone and every part of the Australian healthcare system and community has an essential role to play. It is imperative we work closely together now in a collaborative and organised way to help us get through these challenging times.

Our Responsibility as Medicines Australia and as an industry

As an industry and member of the Australian healthcare community – our critical priorities, at the present time, must be:

  • Focusing our expertise and capabilities in the fight against COVID19 – to uncover the urgently needed measures to protect and treat the community.
  • Ensuring the supply of essential medicines to patients in our community who need them.
  • Working collaboratively with Government and other organisations to actively manage and pre-empt the healthcare delivery needs as they emerge.
  • Recognising and supporting Australia’s healthcare professionals working on the frontline.
  • Working with Healthcare Organisations, Consumer Groups and Patient Advocacy groups to ensure they are kept up to date with relevant information to share with their communities.
  • Our collaboration with research institutions will continue to ensure they have support needed to maintain their important scientific work. This includes maintaining clinical trials, where feasible, to facilitate their completion and assessment.
  • We continue to work with the Therapeutic Goods Administration and Pharmaceutical Benefits Advisory Committee to introduce new medicines and vaccines as they become available.

Medicines supply to the community

In these difficult times we want to reinforce the following

  • Australia has sufficient supplies of medicines and we strongly discourage stockpiling or panic buying of medicines, please only obtain the medicines you immediately need.
  • We have encouraged pharmacists and GPs to help manage our supply of medicines and support the Government’s purchasing limits on selected medicines;
  • We are working in close partnership with Federal (and State) Governments and the local healthcare community to respond to the unprecedented surge in demand.
  • As an industry our companies are working around the clock to monitor and assess our supplies, locally and globally, to ensure they can get to where they are needed.
  • Our manufacturing facilities around the world are open and continue to make millions of doses of medicines and vaccines every day. Strict measures are in place to ensure our teams and facilities are protected and able to maintain production.
  • We want to ensure everyone works together on this – including pharmacists and doctors – so we can ensure our medicines are available to everyone that needs them.

We are in this together

Continuity of Care Collaboration

An open letter to Australians.

In an unprecedented move, a unique collaboration of 15 Australian health organisations (Pathology Awareness Australia, Australian Diabetes Society, RACGP, Medicines Australia, National Rural Health Alliance, Consumer Health Forum, Australian Primary Health Nurses Association, Heart Foundation, Allied Health Professions Australia, Prostrate Cancer Foundation Australia, Australian College of Rural and Remote Medicine, Jean Hailes Foundation, Royal College of Pathologist of Australasia, Australian Patient Association and Patient Voice Initiative) have come together to actively support those living with chronic health conditions to manage and monitor their health, and advocate for preventative health during the COVID-19 pandemic and minimise the post COVID-19 community health legacy.

The Continuity of Care Collaboration (CCC) is an Australian first national communication collaboration of Peak Bodies, Industry and Healthcare Organisations coming together to stress the importance for people to continue monitoring their health and maintaining their regular care. The Continuity of Care Collaboration (CCC) represents the broad healthcare ecosystem, including physicians, nurses, allied health professionals and patient organisations. The group formed with mounting concerns that Australians are not maintaining their regular general practice or other healthcare visits for existing chronic conditions and/or putting off seeing their doctor to get a test, investigation, or immunisation due to fears of contracting COVID-19 or burdening the health system.

The Collaboration believes patient safety and continuity of care has never been more important, particularly for those patients who have chronic and complex diseases or conditions, vulnerable populations, the elderly and immunocompromised. For more information click here

A range of social media materials has been developed and is available for adaptation and use.

Please click here to view

Frequently asked questions

Practical tips and information for patients

Here are links to practical and useful information to support patients during these challenging times:

  • Coronavirus (COVID-19) – Official Australian Government information
  • COVID-19 Hotline 1800 020 080.
  • Consumer Health Forum (CHF) – CHF has been extremely busy on two fronts: Providing essential patient information on COVID-19 and advocating for policy change to help support patient and healthcare professionals safety during the COVID-19 pandemic.
  • World Health Organization (WHO) – provides up to date information from an international perspective around COVID-19.
  • List of helpful resources for maintaining your mental health during social isolation.

Regular e-newsletters to HCOs

Here are a list of email updates about COVID-19 that have been sent out to Health Consumer Organisations by Medicines Australia:

If you want to subscribe to our e-newsletters or find out more information about our work, please email pkeogh@medaus.com.au

Top